Literature DB >> 3965160

Rescue of rats from large dose cyclophosphamide toxicity using protein A.

P K Ray, M Dohadwala, S K Bandyopadhyay, P Canchanapan, D McLaughlin.   

Abstract

Cyclophosphamide (Cy) is widely used as an effective cytotoxic drug, but its use is limited because of its toxicity. In this report, we describe for the first time the ability of purified protein A (P) of Staphylococcus aureus to reduce Cy-induced toxicity in rats. Protein A-treated animals recover quickly from the toxic effects of Cy. The antitumor property of Cy is not reduced in the P + Cy group. In fact, the latter showed a persistent decrease in tumor volume compared with the Cy group. Protein A may prove to be an effective agent in increasing the therapeutic index of Cy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3965160     DOI: 10.1007/bf00552727

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  21 in total

1.  Cyclophosphamide and urinary bladder toxicity.

Authors:  F S PHILIPS; S S STERNBERG; A P CRONIN; P M VIDAL
Journal:  Cancer Res       Date:  1961-12       Impact factor: 12.701

2.  Protein A from Staphylococcus aureus-a mitogen for human T lymphocytes and B lymphocytes but not L lymphocytes.

Authors:  T Sakane; I Green
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

3.  Acetylcysteine in the prevention of cyclophosphamide-induced cystitis in rats.

Authors:  J A Botta; L W Nelson; J H Weikel
Journal:  J Natl Cancer Inst       Date:  1973-09       Impact factor: 13.506

4.  Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. X. Effect of treatment on tumor cell kinetics in mice.

Authors:  B Fisher; N Gunduz
Journal:  J Natl Cancer Inst       Date:  1979-06       Impact factor: 13.506

5.  The effect of N-acetyl cysteine on cyclophosphamide cystitis.

Authors:  D A Tolley
Journal:  Br J Urol       Date:  1977

Review 6.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

7.  gamma-Interferon induced by S. aureus protein A augments natural killing and ADCC.

Authors:  W J Catalona; T L Ratliff; R E McCool
Journal:  Nature       Date:  1981-05-07       Impact factor: 49.962

8.  Bacillus Calmette-Guérin enhancement of colony-stimulating activity and myeloid colony formation following administration of cyclophosphamide.

Authors:  S Ladisch; G H Reaman; D G Poplack
Journal:  Cancer Res       Date:  1979-07       Impact factor: 12.701

9.  Clinical use of immunosuppressive drugs: part II.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

10.  Augmentation and inhibition of delayed hypersensitivity by Staphylococcus aureus protein A.

Authors:  F M Cowan; D L Klein; G R Armstrong; J W Pearson
Journal:  Biomedicine       Date:  1979-11
View more
  3 in total

Review 1.  Stress genes and species survival.

Authors:  P K Ray
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

2.  In vivo protection by protein A of hepatic microsomal mixed function oxygenase system of cyclophosphamide-treated rats.

Authors:  M Dohadwala; P K Ray
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

Review 3.  Protective role of stress genes.

Authors:  P K Ray
Journal:  Environ Health Perspect       Date:  1998-05       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.